SCHEMBL5607136

SCHEMBL5607136

CCC(=Cc1ccc(OCc2ccccc2)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.59
MAPT P10636 4/20 0.49
KDM4E B2RXH2 3/20 0.49
GAA P10253 2/20 0.49
RAB9A P51151 2/20 0.49
PPARG P37231 1/20 0.49
PPARA Q07869 1/20 0.49
NPC1 O15118 1/20 0.49
GSK3B P49841 3/20 0.49
BACE1 P56817 3/20 0.49
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
MAOB P27338 2/20 0.47
NR4A1 P22736 1/20 0.46
NR4A2 P43354 1/20 0.46
NR4A3 Q92570 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
ALDH1A1 P00352 2/20 0.44
ABCG2 Q9UNQ0 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607291 0.91 NR1H4 (0.57) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5606696 0.89 NR1H4 (0.55) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5607676 0.86 NR1H4 (0.63) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5606740 0.85 NR1H4 (0.58) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5607559 0.85 NR1H4 (0.77) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL3978528 0.84 NR1H4 (0.64) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5607131 0.83 NR1H4 (0.67) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5607134 0.83 NR1H4 (0.67) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5606735 0.83 NR1H4 (0.56) NR1H4MAPTKDM4EGAARAB9A
SCHEMBL5606731 0.83 NR1H4 (0.56) NR1H4MAPTKDM4EGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR NR1H4 220/4885MAPT 4570/4885KDM4E 3298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.